Advisory Resource Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Advisory Resource Group's NVO Position: Q1 2026 in Review
Advisory Resource Group sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 27,523 shares — an estimated $1.4M sold.
Advisory Resource Group first reported a position in NVO in Q2 2021 and held it in 18 quarters. The position peaked at $1.4M in Q4 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Advisory Resource Group reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Advisory Resource Group sold 27,523 Novo Nordisk shares in Q1 2026, an estimated $1.4M.
- Advisory Resource Group first reported a position in Novo Nordisk in Q2 2021 and held it in 18 quarters.
- Advisory Resource Group's Novo Nordisk position peaked at $1.4M in Q4 2025.
- 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Advisory Resource Group's 13F filing for Q1 2026, filed 15 May 2026.